The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Treatment of substance abusing patients with comorbid psychiatric disorders
Open accessAbstract
Objective To update clinicians on the latest in evidence-based treatments for substance use disorders (SUD) and non-substance use disorders among adults and suggest how these treatments can be combined into an evidence based process that enhances treatment effectiveness in comorbid patients. Method Articles were extracted from Pubmed using the search terms “dual diagnosis,” “comorbidity” and “co-occurring” and were reviewed for evidence of effectiveness for pharmacologic and psychotherapeutic treatments of comorbidity. Results Twenty-four research reviews and 43 research trials were reviewed. The preponderance of the evidence suggests that antidepressants prescribed to improve substance-related symptoms among patients with mood and anxiety disorders are either not highly effective or involve risk due to high side-effect profiles or toxicity. Second-generation antipsychotics are more effective for treatment of schizophrenia and comorbid substance abuse and current evidence suggests clozapine, olanzapine and risperidone are among the best. Clozapine appears to be the most effective of the antipsychotics for reducing alcohol, cocaine and cannabis abuse among patients with schizophrenia. Motivational interviewing has robust support as a highly effective psychotherapy for establishing a therapeutic alliance. This finding is critical since retention in treatment is essential for maintaining effectiveness. Highly structured therapy programs that integrate intensive outpatient treatments, case management services and behavioral therapies such as Contingency Management (CM) are most effective for treatment of severe comorbid conditions. Conclusions Creative combinations of psychotherapies, behavioral and pharmacological interventions offer the most effective treatment for comorbidity. Intensity of treatment must be increased for severe comorbid conditions such as the schizophrenia/cannabis dependence comorbidity due to the limitations of pharmacological treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
Motivational interviewing: preparing people for change.
Miller, W. R., & Rollnick, S. (2002) · Guilford Press eBooks · Cited by 7,770
(1991) · Medical Entomology and Zoology · Cited by 4,438
The fifth edition of the addiction severity index
McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,222
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review
Martin, D. J., Garske, J. P., & Davis, M. K. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.3.438 · Cited by 3,355
Defining empirically supported therapies.
Chambless, D. L., & Hollon, S. D. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.7 · Cited by 3,067
Relation between working alliance and outcome in psychotherapy: A meta-analysis
Horvath, A. O., & Symonds, B. D. (1991) · Journal of Counseling Psychology · doi:10.1037/0022-0167.38.2.139 · Cited by 2,673
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Cited by
Alcohol use disorder and depressive disorders
McHugh, R. (2019) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v40.1.01 · Cited by 517
Psychiatric comorbidities in alcohol use disorder
Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30222-6 · Cited by 444
Update on Typical and Atypical Antipsychotic Drugs
Meltzer, H. Y. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050911-161504 · Cited by 433
Frost, H., Campbell, P., Maxwell, M., O’Carroll, R. E., Dombrowski, S. U., Williams, B., Cheyne, H., Coles, E., & Pollock, A. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204890 · Cited by 413
Integrated treatment of substance use and psychiatric disorders
Kelly, T. M., & Daley, D. C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.774673 · Cited by 378
Self-citationComorbidity between major depression and alcohol use disorder from adolescence to adulthood
Brière, F. N., Rohde, P., Seeley, J. R., Klein, D., & Lewinsohn, P. M. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.10.007 · Cited by 328
“Treatment recommendations exist and should be used when addressing concurrent comorbidity [38].”
Hunt, G. E., Malhi, G. S., Lai, H. M. X., & Cleary, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.141 · Cited by 289
Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse
Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T., & Cleary, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt160 · Cited by 266
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Khan, A., Tansel, A., White, D. L., Kayani, W. T., Bano, S., Lindsay, J., El-Serag, H. B., & Kanwal, F. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.047 · Cited by 179
Treatment of Dual Diagnosis Disorders
Murthy, P., & Chand, P. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328351a3e0 · Cited by 115
Psychosocial interventions for people with both severe mental illness and substance misuse
Hunt, G. E., Siegfried, N., Morley, K., Brooke-Sumner, C., & Cleary, M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001088.pub4 · Cited by 105
Deady, M., Mills, K. L., Teesson, M., & Kay-Lambkin, F. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5178 · Cited by 105
Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.11.022 · Cited by 102
Psychiatric disease and drug abuse
Santucci, K. (2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283504fbf · Cited by 97
Medications for substance use disorders
Douaihy, A. B., Kelly, T. M., & Sullivan, C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.759031 · Cited by 93
Self-citationA Review of Integrated Care for Concurrent Disorders: Cost Effectiveness and Clinical Outcomes
Karapareddy, V. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2018.1518553 · Cited by 77
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
“Integrated care recognizes that these external factors play a pivotal role in an individual’s overall well-being and treatment outcome [16].”
BackgroundTreatment for Substance Use Disorder with Co-Occurring Mental Illness
Iqbal, M. N., Levin, C. J., & Levin, F. R. (2019) · Focus · doi:10.1176/appi.focus.20180042 · Cited by 66
Treatments for Co-Occurring Depression and Substance Use in Young People: A Systematic Review
Deady, M., Teesson, M., & Kay-Lambkin, F. (2014) · Current Drug Abuse Reviews · doi:10.2174/1874473707666141015220608 · Cited by 25
Theis (2016) · doi:10.1016/j.cnur.2016.01.007 · Cited by 24
Green, J., Bagge, A. S. L., Olausson, S., Andiné, P., Wallinius, M., & Karlén, M. H. (2023) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108899 · Cited by 9
Current Challenges With Comorbid Psychiatric and Substance Use Disorders
Crockford, D. (2021) · Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000121 · Cited by 1
Metadata
- Authors
- Kelly, T. M., Daley, D. C., & Douaihy, A. B.
- Venue
- Addictive Behaviors
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 37
- Issue
- 1
- Pages
- 11-24
- ISSN
- 0306-4603 (ISSN-L)
- OpenAlex
- W2067567375
- Cited by
- 284
- References
- 193
- FWCI
- 17.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.